These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 36671282)

  • 1. Synergistic Activity of Pep16, a Promising New Antibacterial Pseudopeptide against Multidrug-Resistant Organisms, in Combination with Colistin against Multidrug-Resistant
    Chosidow S; Fantin B; Nicolas I; Mascary JB; Chau F; Bordeau V; Verdier MC; Rocheteau P; Guérin F; Cattoir V; de Lastours V
    Antibiotics (Basel); 2023 Jan; 12(1):. PubMed ID: 36671282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of the combination of colistin and fosfomycin against NDM-1-producing Escherichia coli with variable levels of susceptibility to colistin and fosfomycin in a murine model of peritonitis.
    Le Menestrel A; Guerin F; Chau F; Massias L; Benchetrit L; Cattoir V; Fantin B; de Lastours V
    J Antimicrob Chemother; 2021 Dec; 77(1):155-163. PubMed ID: 34718597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of fosfomycin alone or combined with temocillin in vitro and in a murine model of peritonitis due to KPC-3- or OXA-48-producing Escherichia coli.
    Berleur M; Guérin F; Massias L; Chau F; Poujade J; Cattoir V; Fantin B; de Lastours V
    J Antimicrob Chemother; 2018 Nov; 73(11):3074-3080. PubMed ID: 30085154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The inoculum effect of Escherichia coli expressing mcr-1 or not on colistin activity in a murine model of peritonitis.
    Fantin B; Poujade J; Grégoire N; Chau F; Roujansky A; Kieffer N; Berleur M; Couet W; Nordmann P
    Clin Microbiol Infect; 2019 Dec; 25(12):1563.e5-1563.e8. PubMed ID: 31494253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining Colistin with Furanone C-30 Rescues Colistin Resistance of Gram-Negative Bacteria
    Zhang Y; Lin Y; Zhang X; Chen L; Xu C; Liu S; Cao J; Zheng X; Jia H; Chen L; Zhou T
    Microbiol Spectr; 2021 Dec; 9(3):e0123121. PubMed ID: 34730415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular activity and
    Mascary JB; Bordeau V; Nicolas I; Verdier MC; Rocheteau P; Cattoir V
    JAC Antimicrob Resist; 2024 Feb; 6(1):dlae025. PubMed ID: 38410249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of antimicrobial peptide CDP-B11 alone and in combination with colistin against colistin-resistant and multidrug-resistant Escherichia coli.
    Witherell KS; Price J; Bandaranayake AD; Olson J; Call DR
    Sci Rep; 2021 Jan; 11(1):2151. PubMed ID: 33495505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colistin/daptomycin: an unconventional antimicrobial combination synergistic in vitro against multidrug-resistant Acinetobacter baumannii.
    Galani I; Orlandou K; Moraitou H; Petrikkos G; Souli M
    Int J Antimicrob Agents; 2014 Apr; 43(4):370-4. PubMed ID: 24560919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mefloquine enhances the activity of colistin against antibiotic-resistant Enterobacterales in vitro and in an in vivo animal study.
    Hu Y; Coates A
    Int J Antimicrob Agents; 2021 Apr; 57(4):106309. PubMed ID: 33609719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vitro synergistic activity of colistin and meropenem against clinical isolates of carbapenem resistant E.coli and Klebsiella pneumoniae by checkerboard method.
    Dhandapani S; Sistla S; Gunalan A; Manoharan M; Sugumar M; Sastry AS
    Indian J Med Microbiol; 2021 Jan; 39(1):6-10. PubMed ID: 33516606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic effect of eugenol with Colistin against clinical isolated Colistin-resistant
    Wang YM; Kong LC; Liu J; Ma HX
    Antimicrob Resist Infect Control; 2018; 7():17. PubMed ID: 29423192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic effect of antimicrobial peptide LL-37 and colistin combination against multidrug-resistant
    Morroni G; Sante LD; Simonetti O; Brescini L; Kamysz W; Kamysz E; Mingoia M; Brenciani A; Giovanetti E; Bagnarelli P; Giacometti A; Cirioni O
    Future Microbiol; 2021 Mar; 16():221-227. PubMed ID: 33646013
    [No Abstract]   [Full Text] [Related]  

  • 13. Nordihydroguaiaretic acid reverses the antibacterial activity of colistin against MCR-1-positive bacteria in vivo/in vitro by inhibiting MCR-1 activity and injuring the bacterial cell membrane.
    Song G; Zhou Y; Niu S; Deng X; Qiu J; Li L; Wang J
    Phytomedicine; 2022 Apr; 98():153946. PubMed ID: 35158237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New therapy from old drugs: synergistic bactericidal activity of sulfadiazine with colistin against colistin-resistant bacteria, including plasmid-mediated colistin-resistant mcr-1 isolates.
    Okdah L; Le Page S; Olaitan AO; Dubourg G; Hadjadj L; Rolain JM
    Int J Antimicrob Agents; 2018 May; 51(5):775-783. PubMed ID: 29421171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased activity of colistin in combination with amikacin against Escherichia coli co-producing NDM-5 and MCR-1.
    Zhou YF; Tao MT; Feng Y; Yang RS; Liao XP; Liu YH; Sun J
    J Antimicrob Chemother; 2017 Jun; 72(6):1723-1730. PubMed ID: 28333193
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Zhou C; Wang Q; Jin L; Wang R; Yin Y; Sun S; Zhang J; Wang H
    Front Microbiol; 2020; 11():533209. PubMed ID: 33193122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic Antimicrobial Activity of Colistin in Combination with Rifampin and Azithromycin against Escherichia coli Producing MCR-1.
    Li Y; Lin X; Yao X; Huang Y; Liu W; Ma T; Fang B
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30224527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial activity of carbon monoxide-releasing molecule [Mn(CO)3(tpa-κ3N)]Br versus multidrug-resistant isolates of Avian Pathogenic Escherichia coli and its synergy with colistin.
    Betts J; Nagel C; Schatzschneider U; Poole R; La Ragione RM
    PLoS One; 2017; 12(10):e0186359. PubMed ID: 29040287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic Effects of Capric Acid and Colistin against Colistin-Susceptible and Colistin-Resistant
    Liu YY; Qin ZH; Yue HY; Bergen PJ; Deng LM; He WY; Zeng ZL; Peng XF; Liu JH
    Antibiotics (Basel); 2022 Dec; 12(1):. PubMed ID: 36671237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral administration of a 2-aminopyrimidine robenidine analogue (NCL195) significantly reduces
    Nguyen HT; Venter H; Woolford L; Young KA; McCluskey A; Garg S; Sapula SS; Page SW; Ogunniyi AD; Trott DJ
    Antimicrob Agents Chemother; 2023 Oct; 67(10):e0042423. PubMed ID: 37695304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.